EIT Pharma
EIT Pharma is headquartered in Kirkland, United States, lists 1–10 employees, and has $35.0M in recorded funding across 1 round.
- Headquarters
- Kirkland, Washington
- Employees
- 1–10
- Website
- eitpharma.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AAug 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
EIT Pharma develops treatments for Hepatitis D and Acute Respiratory Infection, now in development. Its lead candidate is in Phase 3 of development for chronic hepatitis D, and a second program is in Phase 2 of development for chronic hepatitis D and acute respiratory infection. An estimated 12 million people worldwide have been affected by Hepatitis D (HDV), which has no FDA-approved treatment in the United States, while Acute Respiratory Infection remains one of the leading causes of death globally and places a significant economic strain on both patients and healthcare systems.
Summary
EIT Pharma is a Biotech company based in Kirkland, United States. It lists 1–10 employees. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Aug 2026. Investors include Propel Bio Partners and Good Ventures.
Funding History
Aug 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/eit-pharma"><img src="https://indexed.vc/api/badge/company/eit-pharma" alt="EIT Pharma on Indexed.vc" width="260" height="76" /></a>